Over its 49 years of history, Deva has accomplished to register 170 products ranging from antimicrobial agents to antineoplastics and antihypertensives. 75 of these previously registered products are currently in the Turkish pharmaceutical market. This only by itself is enough to demonstrate the competency of Deva in predicting the behavioral changes of the sector to sustain its solid momentum.

Needless to mention, as Turkey is placed itself in the regulated market whatever regulatory rule applies to the EU countries, so does it in Turkey, such that everything has to be supplied in the CTD format. To expedite the licensing process setting our target high at the same time, we established two different segments in our company to handle licensing issues: